eConsent Resources

  1. Patient Perspectives On eConsent 12/20/2023

    Explore how eConsent enables participants to engage meaningfully with consent documentation, addressing information dissemination, explanation, and recall challenges.

  2. How Capturing Data Directly Is Transforming Trials 2/3/2023

    With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.

  3. 10 FAQs On eConsent 11/16/2023

    Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.

  4. Designed To Help Sites Increase Clinical Trial Capacity 7/25/2025

    IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.

  5. Going Global With eConsent 4/20/2022

    Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.

  6. Addressing Site And Sponsor Challenges In Digital Trials 10/10/2023

    <p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>

  7. Agile eConsent: Taking A Flexible Approach To Global Implementation 6/28/2022

    Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.

  8. Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations 2/22/2023

    Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.

  9. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

    Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

  10. How To Prepare An IRB Submission For A Remote eConsent Study 1/24/2022

    IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.